Found: 12
Select item for more details and to access through your institution.
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 166, doi. 10.3390/vaccines12020166
- By:
- Publication type:
- Article
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267372
- By:
- Publication type:
- Article
The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1585, doi. 10.1093/cid/ciac944
- By:
- Publication type:
- Article
Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1119820
- By:
- Publication type:
- Article
Editorial: Puzzle pieces from malaria vaccine clinical trials.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1138763
- By:
- Publication type:
- Article
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.1058081
- By:
- Publication type:
- Article
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.978591
- By:
- Publication type:
- Article
Assessment of Mixed Plasmodium falciparum sera5 Infection in Endemic Burkitt Lymphoma: A Case-Control Study in Malawi.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1692, doi. 10.3390/cancers13071692
- By:
- Publication type:
- Article
Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
- Published in:
- Malaria Journal, 2017, v. 16, p. 1, doi. 10.1186/s12936-016-1663-1
- By:
- Publication type:
- Article
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064073
- By:
- Publication type:
- Article
Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 8, p. 1908, doi. 10.1002/ijc.26203
- By:
- Publication type:
- Article
Divergence of the Mitochondrial Genome Structure in the Apicomplexan Parasites, Babesia and Theileria.
- Published in:
- Molecular Biology & Evolution, 2010, v. 27, n. 5, p. 1107, doi. 10.1093/molbev/msp320
- By:
- Publication type:
- Article